Investment

Edging ahead in Q2 but still held back:

Investment review for January to March 2023. “If you’re going through hell, keep going.” Winston Churchill:

Full year 2022 report on the state of longevity investment: the numbers, the sectors, the top deals, the key players and the outlook for 2023:

Disease management to disease modification – removing plaque to undo atherosclerosis:

Delaying the menopause to increase women’s healthspan:

Leading a new era of personalised, preventative health and optimal aging:

Supplementing your Longevity supplement knowledge:

Managing senescent cells to drive human longevity: